Searched for
COVOVAX VACCINE
Serum Institute of India restarts manufacturing of COVID-19 vaccine CovishieldReacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand. "Just as a precaution, at ...- Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...
- NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portalThe DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9,...
- SII gets govt nod to export 32.4 lakh doses of Covovax vaccine to USIn a letter to the government on June 29, Prakash Kumar Singh, director (government and regulatory affairs) at SII had sought permission to...
- Covovax may be available soon in private market for 12-17 year oldsThe vaccine was approved for use in the age group by the National Technical Advisory Group on Immunisation (NTAGI) last week.
- Covovax for 7-12-year-olds: Panel seeks more dataSII had presented interim safety and immunogenicity data of a two-month period after the second dose of Covovax was administered to 225 par...
- SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold in EuropePoonawalla, in an exclusive interview with ANI, said, "We have a stockpile of 200 million doses of Covishield...We've already exported 40 m...
- Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and aboveThe COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...
- NTAGI's Covid working group to review SII's Covovax data for use in 12 year olds and aboveIndia's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years a...
- India's drugs regulator gives nod to phase-3 clinical trial of Covid vaccine CovovaxCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- DCGI's EUA nod to SII's Covovax for 12-17 yrs age group; Poonawalla says younger age groups to follow shortlyIt is the fourth vaccine to receive the regulator's nod for use among those below 18 years.
- SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- SII set to export 25 crore Covovax doses for Covax from next monthIndia's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...
- Covovax better booster for Covishield-vaccinated people: Dr Shahid Jameel, VirologistIndia is gearing up to tackle a possible third wave of the coronavirus pandemic as the Omicron variant of the virus, which is said to be mu...
- Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
- CDSCO panel recommends emergency use authorisation for SII's Covid vaccine Covovax"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use autho...
- WHO nod boosts Covovax chances of getting approval in IndiaCovovax is being manufactured in India by the Serum Institute of India (SII).
- Serum Institute manufacturing first batch of Covovax COVID-19 vaccine, says Adar PoonawallaIn March this year, Poonawalla had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it ...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
Load More
